Flerie
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Flerie's portfolio company Nanologica has received an important order from a new customer
Stockholm, 24 April, 2025. Flerie AB's (publ) portfolio company Nanologica has announced that the company has secured an order for its silica-based purification media NLAB Saga® from a new customer in China.
The order for NLAB Saga® amounts to USD 180,000 and is expected to be delivered in the second quarter. The customer is a large pharmaceutical manufacturer and the order is for the evaluation of NLAB Saga® at production scale for use in the production of GLP-1 analogs, a rapidly growing area globally for the treatment of type 2 diabetes and obesity.
"This is very good news for Nanologica and an important step into the rapidly growing and strategically important GLP-1 segment. We look forward to following the company's continued development in China." says Mark Quick, Partner at Flerie.
Read Nanologica's full press release here: nanologica-ab-receives-order-worth-usd-180-000-from-new-customer-in-china.pdf
Flerie's holding in Nanologica amounts to 43%.
For more information:
Mark Quick
Email: ir@flerie.com
| Datum | 2025-04-24, kl 10:15 |
| Källa | MFN |